Selected Publications
Naka K, Ishihara K, Jomen Y, Jin CH, Kim DH, Gu YK, Jeong ES, Li S, Krause DS, Kim DW, Bae E, Takihara Y, Hirao A, Oshima H, Oshima M, Ooshima A, Sheen YY, Kim SJ, Kim DK.
Novel oral transforming growth factor-β signaling inhibitor EW-7197 eradicates CML-initiating cells.
Cancer Sci. 2016 Feb;107(2):140-8. doi: 10.1111/cas.12849. Epub 2016 Jan 26.
PubMedRabenhorst U, Thalheimer F, Gerlach K, Kijonka M, Böhm S, Krause DS, Vauti F, Arnold HH, Schroeder T, Schnütgen F, von Melchner H, Rieger M, Zörnig M
Single-stranded DNA-binding transcriptional regulator FUBP1 is essential for fetal and adult hematopoietic stem cell self-renewal
Cell Rep. 2015 Jun 30;11(12):1847-55.
PubMedMasia R, Krause DS, Yellen G.
The inward rectifier potassium channel Kir2.1 is expressed in mouse neutrophils from bone marrow and liver.
Am J Physiol Cell Physiol. 2015 Feb 1;308(3):C264-76.
PubMedWheat JC*, Krause DS*, Shin TH*, Chen X, Wang J, Ding D, Yasmin R, Sweetser DA.
The corepressor Tle4 is a novel regulator of murine hematopoietic stem and progenitor cells and their niche.
PLoS One. 2014 Aug 25;9(8):e105557. doi: 10.1371/journal.pone.0105557. eCollection 2014.
PubMedKrause DS, Lazarides K, Lewis JB, von Andrian UH, Van Etten RA.
Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche
Blood 2014; 123(9): 1361-1371
PubMedKrause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP, Lezeau S, Attar E, Wu JY, Lin HY, Divieti-Pajevic P, Hasserjian RP, Schipani E, Van Etten RA, Scadden DT
Differential regulation of myeloid leukemias by the bone marrow microenvironment
Nature Medicine 2013; 19(11):1513-1517* *Faculty of 1000 Prime status
PubMedFulzele K*, Krause DS*, Panaroni C, Saini V, Barry KJ, Lotinun S, Baron R, Bonewald L, Feng JQ, Chen M, Weinstein LS, Wu JY, Kronenberg HM, Scadden DT, Divieti-Pajevic P
Myelopoiesis is regulated by osteocytes through Gsa-dependent signaling
Blood 2013 Feb 7;121(6):930-9.
PubMedDemers M, Krause DS, Schatzberg D, Martinod K, Voorhees J, Fuchs TA, Scadden DT, Wagner DD
Cancer predisposes neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
Proc Natl Acad Sci U S A 2012; 109(32):13076
PubMedKrause DS, Spitzer TR, Stowell CP
The concentration of CD44 is increased in hematopoietic stem cell grafts of patients with acute myeloid leukemia, plasma cell myeloma, and non-Hodgkin lymphoma.
Arch Pathol Lab Med 2010; 134(7): 1033-8
PubMedKrause DS, Lazarides K, von Andrian UH, Van Etten RA.
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells
Nat Med 2006; 12 (10):1175-80
PubMedKrause DS, Van Etten RA.
Adoptive Immunotherapy of Bcr/Abl-induced chronic myeloid leukemia-like myeloproliferative disease in a murine model.
Blood 2004; 104: 4236-4244.
PubMedRoumiantsev S*, Krause DS*, Neumann CA, Dimitri CA, Asiedu F, Cross NCP, Van Etten RA.
Distinct stem cell myeloproliferative /T-lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations
Cancer Cell 2004;5:287-298
PubMedPublications – Reviews, editorials, letters to the editor:
Krause DS, Scadden DT
A hostel for the hostile: The stem cell niche in haematological neoplasms
Haematologica 2015;100(11):1376-87Krause DS
Illness and artistic creativity (on the 70th anniversary of the death of Béla Bartók, composer, ethnomusicologist and leukemia patient).
Leukemia 2015;29(12):2417-8Publications – Book chapters:
Krause DS, DeLelys ME, Preffer FI
Flow Cytometry for Hematopoietic Cells
Methods Mol Biol 2014; 1109:23-46Weissenberger ES, Krause DS
Histological and In Vivo Microscopic Analysis of the Bone Marrow Microenvironment in a Murine Model of Chronic Myelogenous Leukemia
Methods Mol Biol. 2016;1465:59-72Verma D, Krause DS
Targeting the bone marrow niche in haematological malignancies
Advances in Stem Cells and Their Niches volume 1, in press